Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Expert Opinion on Drug Safety Volume 22, 2023 - Issue 1

Submit an article Journal homepage

Open access

2,296

Views

CrossRef citations to date

Altmetric

Original Research

Safety profile of lasmiditan in patients with migraine in an Asian population

Koichi Hirataa Headache Center, Dokkyo Medical University, Mibu, JapanView further author information

Yasuhiko Matsumorib Sendai Headache and Neurology Clinic, Sendai, JapanView further author information

Yuka Tanjic Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, JapanView further author information

Rashna Khannad Global Patient Safety, Eli Lilly and Company Limited, Bracknell, UKView further author information

Akichika Ozekic Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, JapanView further author information

Mika Komoric Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, JapanCorrespondence[email protected]
View further author information

Pages 91-101 | Received 28 Mar 2022, Accepted 06 Jun 2022, Published online: 12 Jul 2022

Cite this article
https://doi.org/10.1080/14740338.2022.2087630
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shigekazu Kitamura, Noboru Imai, Yuka Tanji, Akichika Ozeki & Mika Komori. (2023) Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study. Journal of Pain Research 16, pages 1725-1738.
Read now

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references